Marlon Cowart

4.3k total citations · 1 hit paper
71 papers, 3.1k citations indexed

About

Marlon Cowart is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Marlon Cowart has authored 71 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 34 papers in Immunology and 13 papers in Organic Chemistry. Recurrent topics in Marlon Cowart's work include Mast cells and histamine (34 papers), Receptor Mechanisms and Signaling (19 papers) and Olfactory and Sensory Function Studies (10 papers). Marlon Cowart is often cited by papers focused on Mast cells and histamine (34 papers), Receptor Mechanisms and Signaling (19 papers) and Olfactory and Sensory Function Studies (10 papers). Marlon Cowart collaborates with scholars based in United States, United Kingdom and Netherlands. Marlon Cowart's co-authors include Jorge D. Brioni, Craig S. Wilcox, Stephen J. Benkovic, Timothy A. Esbenshade, Arthur A. Hancock, Michael F. Jarvis, Steve McGaraughty, Tiffany Runyan Garrison, Rob Leurs and Helmut L. Haas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Molecular Biology.

In The Last Decade

Marlon Cowart

68 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors

2015 414 citations Marlon Cowart et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marlon Cowart United States	34	1.7k	1.0k	673	394	365	71	3.1k
Henk Timmerman Netherlands	36	2.4k 1.5×	1.8k 1.8×	517 0.8×	521 1.3×	799 2.2×	112	4.2k
Arthur A. Hancock United States	36	2.6k 1.5×	1.6k 1.6×	454 0.7×	565 1.4×	908 2.5×	108	4.1k
H. Timmerman Netherlands	35	2.5k 1.5×	2.2k 2.2×	685 1.0×	777 2.0×	525 1.4×	146	4.3k
Remko A. Bakker Netherlands	36	2.3k 1.4×	1.8k 1.8×	310 0.5×	510 1.3×	798 2.2×	67	3.9k
Michael A. Letavic United States	31	672 0.4×	374 0.4×	662 1.0×	127 0.3×	184 0.5×	69	2.3k
Walter Schunack Germany	40	4.1k 2.5×	4.0k 4.0×	964 1.4×	926 2.4×	756 2.1×	342	6.7k
Steven J. Charlton United Kingdom	34	2.5k 1.5×	433 0.4×	158 0.2×	704 1.8×	1.3k 3.4×	85	3.8k
Michel Gillard Belgium	33	1.3k 0.8×	329 0.3×	302 0.4×	519 1.3×	1.5k 4.2×	92	3.3k
Richard W. Ransom United States	29	2.4k 1.4×	406 0.4×	660 1.0×	293 0.7×	1.9k 5.2×	73	4.4k
Günther Schmalzing Germany	45	2.4k 1.4×	347 0.3×	234 0.3×	526 1.3×	912 2.5×	113	4.8k

Countries citing papers authored by Marlon Cowart

Since Specialization

Citations

This map shows the geographic impact of Marlon Cowart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlon Cowart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlon Cowart more than expected).

Fields of papers citing papers by Marlon Cowart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlon Cowart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlon Cowart. The network helps show where Marlon Cowart may publish in the future.

Co-authorship network of co-authors of Marlon Cowart

This figure shows the co-authorship network connecting the top 25 collaborators of Marlon Cowart. A scholar is included among the top collaborators of Marlon Cowart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlon Cowart. Marlon Cowart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menet, Christel, Caroline Joannesse, Marlon Cowart, et al.. (2021). Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis. Journal of Medicinal Chemistry. 64(1). 343–353. 17 indexed citations

McGaraughty, Steve, Katharine L. Chu, Marlon Cowart, & Jorge D. Brioni. (2012). Antagonism of Supraspinal Histamine H3 Receptors Modulates Spinal Neuronal Activity in Neuropathic Rats. Journal of Pharmacology and Experimental Therapeutics. 343(1). 13–20. 32 indexed citations

Esbenshade, Timothy A., Kaitlin E. Browman, Thomas R. Miller, et al.. (2012). Pharmacological Properties and Procognitive Effects of ABT-288, a Potent and Selective Histamine H3 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 343(1). 233–245. 38 indexed citations

Hsieh, Gin C., Prasant Chandran, Anita K. Salyers, et al.. (2009). H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacology Biochemistry and Behavior. 95(1). 41–50. 69 indexed citations

Miller, Thomas R., John L. Baranowski, David G. Witte, et al.. (2008). A Robust and High-Capacity [ ³⁵ S]GTP γ S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H ₃ Receptor Ligands. Assay and Drug Development Technologies. 6(3). 339–349. 5 indexed citations

Black, Lawrence A., Thomas R. Miller, Timothy A. Vortherms, et al.. (2007). In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: Trends across multiple chemical series. Bioorganic & Medicinal Chemistry Letters. 18(1). 355–359. 12 indexed citations

Zhang, Min, Michael E. Ballard, Liping Pan, et al.. (2005). Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug–drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Brain Research. 1045(1-2). 142–149. 44 indexed citations

Gfesser, Gregory A., Ramin Faghih, Youssef L. Bennani, et al.. (2005). Structure–activity relationships of arylbenzofuran H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(10). 2559–2563. 42 indexed citations

Esbenshade, Timothy A., Gerard B. Fox, Kathleen M. Krueger, et al.. (2005). Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties. Journal of Pharmacology and Experimental Therapeutics. 313(1). 165–175. 84 indexed citations

10.

Nakane, Masaki, Marlon Cowart, Gin C. Hsieh, et al.. (2005). 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Neuropharmacology. 49(1). 112–121. 14 indexed citations

11.

Brioni, Jorge D., Robert B. Moreland, Marlon Cowart, et al.. (2004). Activation of dopamine D ₄ receptors by ABT-724 induces penile erection in rats. Proceedings of the National Academy of Sciences. 101(17). 6758–6763. 100 indexed citations

12.

Cowart, Marlon, Robert J. Altenbach, Lawrence A. Black, et al.. (2004). Medicinal Chemistry and Biological Properties of Non-Imidazole Histamine H3 Antagonists. Mini-Reviews in Medicinal Chemistry. 4(9). 979–992. 54 indexed citations

13.

Hancock, Arthur A., Ramin Faghih, Eugene N. Bush, et al.. (2004). In vitro Optimization of Structure Activity Relationships of Analogues of A‐331440 Combining Radioligand Receptor Binding Assays and Micronucleus Assays of Potential Antiobesity Histamine H₃ Receptor Antagonists. Basic & Clinical Pharmacology & Toxicology. 95(3). 144–152. 22 indexed citations

14.

Curtis, Michael P., John K. Pratt, Marlon Cowart, et al.. (2004). D‐Amino Acid Homopiperazine Amides: Discovery of A‐320436, a Potent and Selective Non‐Imidazole Histamine H₃‐Receptor Antagonist. Archiv der Pharmazie. 337(4). 219–229. 13 indexed citations

15.

Gfesser, Gregory A., Erol K. Bayburt, Marlon Cowart, et al.. (2003). Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors. European Journal of Medicinal Chemistry. 38(3). 245–252. 31 indexed citations

16.

McGaraughty, Steve, Katharine L. Chu, Carol T. Wismer, et al.. (2001). Effects of A-134974, a Novel Adenosine Kinase Inhibitor, on Carrageenan-Induced Inflammatory Hyperalgesia and Locomotor Activity in Rats: Evaluation of the Sites of Action. Journal of Pharmacology and Experimental Therapeutics. 296(2). 501–509. 37 indexed citations

17.

Cowart, Marlon, Gregory A. Gfesser, Erol K. Bayburt, et al.. (2001). Structure–activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(1). 83–86. 24 indexed citations

18.

McNally, Teresa, Rosalind Helfrich, Marlon Cowart, et al.. (1997). Cloning and Expression of the Adenosine Kinase Gene from Rat and Human Tissues. Biochemical and Biophysical Research Communications. 231(3). 645–650. 49 indexed citations

19.

Cowart, Marlon, Stephen J. Benkovic, & Howard A. Nash. (1991). Behavior of a cross-linked attachment site: Testing the role of branch migration in site-specific recombination. Journal of Molecular Biology. 220(3). 621–629. 8 indexed citations

20.

Carroll, Steven S., Marlon Cowart, & Stephen J. Benkovic. (1991). A mutant of DNA polymerase I (Klenow fragment) with reduced fidelity. Biochemistry. 30(3). 804–813. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact